Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362579 · ClinicalTrials.gov registry record
Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 91
- Enrollment target
NCT04362579: Completed study, sponsored by Northwestern University.
NCT04362579 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04362579 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Primary Outcome
The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems.
Interventions
- DEVICE wearable vital signs sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2021-12-01 |
What the finished NCT04362579 record still lists
NCT04362579 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which wearable vital signs sensor is the first listed.
NCT04362579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04362579 about?
NCT04362579 is a clinical study titled "Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor". Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
What is the current status of trial NCT04362579?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2021-01-01. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04362579?
The interventions under investigation include: wearable vital signs sensor (DEVICE).
Who is sponsoring clinical trial NCT04362579?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI